Marginal biotin deficiency during normal pregnancy
Authors:
Open Access
- 1 February 2002
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 75 (2) , 295-299
Abstract
Background: Biotin deficiency is teratogenic in several mammalian species. Approximately 50% of pregnant women have an abnormally increased urinary excretion of 3-hydroxyisovaleric acid (3-HIA), which probably reflects decreased activity of the biotin-dependent enzyme methylcrotonyl-CoA carboxylase. However, increased 3-HIA excretion could result from pregnancy per se (eg, from an effect of pregnancy on renal handling of organic acids). Objective: We tested the hypothesis that biotin supplementation significantly decreases 3-HIA excretion in pregnant women with abnormally increased 3-HIA excretion. Design: Twenty-six pregnant women with increased 3-HIA excretion were studied in a randomized, placebo-controlled trial; 10 women were studied during early pregnancy (6–17 wk gestation) and 16 women during late pregnancy (21–37 wk gestation). Urine samples were collected before and after 14 d of supplementation with 300 μg (1.2 μmol) biotin/d or placebo. Results: In the early-pregnancy group, 3-HIA excretion decreased (P < 0.006) by 11.7 ± 3.6 mmol/mol creatinine (mean ± SEM) in the 5 women who received biotin supplements, whereas 3-HIA excretion increased by 1.6 ± 0.6 mmol/mol creatinine in the 5 women who received placebo. In the late-pregnancy group, 3-HIA excretion decreased (P < 0.002) by 7.1 ± 1.2 mmol/mol creatinine in the 8 women who received biotin supplements, whereas 3-HIA excretion increased by 0.9 ± 1.8 mmol/mol creatinine in the 8 women who received placebo. Conclusions: This study provides evidence that the increased excretion of 3-HIA seen frequently in normal pregnancy reflects reduced biotin status. The conclusion that marginal biotin deficiency occurs frequently in the first trimester further raises concern about potential human teratogenicity.Keywords
This publication has 13 references indexed in Scilit:
- Indicators of marginal biotin deficiency and repletion in humans: validation of 3-hydroxyisovaleric acid excretion and a leucine challenge,,The American Journal of Clinical Nutrition, 2002
- Marginal Biotin Deficiency Is TeratogenicProceedings of the Society for Experimental Biology and Medicine, 2000
- MATERNAL BIOTIN DEFICIENCY CAUSES FETAL MALFORMATIONS BY INDUCING FETAL BIOTIN DEFICIENCYJournal of Pediatric Gastroenterology and Nutrition, 1999
- Disturbances in Biotin Metabolism in Children Undergoing Long-Term Anticonvulsant TherapyJournal of Pediatric Gastroenterology and Nutrition, 1998
- Conflicting indicators of biotin status from a cross-sectional study of normal pregnancy.Journal of the American College of Nutrition, 1997
- Biotin Status Assessed Longitudinally in Pregnant WomenThe Journal of Nutrition, 1997
- [28] Determinations of biotin in biological fluids1997
- Teratogenic effects of maternal biotin deficiency on mouse embryos examined at midgestationTeratology, 1990
- Quantification of urinary 3-hydroxyisovaleric acid using deuterated 3-hydroxyisovaleric acid as internal standardJournal of Mass Spectrometry, 1989
- Vitamin Status during Puerperium and LactationAnnals of Nutrition and Metabolism, 1984